Total Visits

Views
A pooled analysis of two randomized, double-blind placebo-controlled Phase III trials (STARTVerso1&2) of faldaprevir plus pegylated interferon alfa-2a and ribavirin in treatment-naive patients with chronic hepatitis C genotype-1 infection49

Select a period of time:

Views

Views
April 20252
May 20250
June 20250
July 202519
August 20250
September 20254
October 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States9
Brazil8
United Kingdom3
Chile1
Spain1
Tunisia1
Turkey1
Venezuela1
 

Top cities views

Views
Dallas3
Augusta1
Barquisimeto1
Batley1
Brasília1
Council Bluffs1
Deer Park1
El Fahs1
Istanbul1
Jaguarão1